KEGG   PATHWAY: zca04115
Entry
zca04115                    Pathway                                
Name
p53 signaling pathway - Zalophus californianus (California sea lion)
Description
p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways.
Class
Cellular Processes; Cell growth and death
Pathway map
zca04115  p53 signaling pathway
zca04115

Organism
Zalophus californianus (California sea lion) [GN:zca]
Gene
113908182  PPM1D; protein phosphatase 1D [KO:K10147] [EC:3.1.3.16]
113908849  THBS1; thrombospondin-1 [KO:K16857]
113909591  CASP9; LOW QUALITY PROTEIN: caspase-9 [KO:K04399] [EC:3.4.22.62]
113909653  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X1 [KO:K04402]
113910151  CCNB2; G2/mitotic-specific cyclin-B2 isoform X1 [KO:K21770]
113910549  SIVA1; apoptosis regulatory protein Siva isoform X1 [KO:K22744]
113910965  ADGRB1; adhesion G protein-coupled receptor B1 isoform X1 [KO:K04596]
113911106  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
113911261  [KO:K08738]
113911741  TP73; tumor protein p73 isoform X3 [KO:K10148]
113911843  IGFBP3; insulin-like growth factor-binding protein 3 [KO:K10138]
113912489  BCL2; apoptosis regulator Bcl-2 isoform X1 [KO:K02161]
113912835  SERPINB5; serpin B5 [KO:K10139]
113912998  CHEK2; serine/threonine-protein kinase Chk2 isoform X1 [KO:K06641] [EC:2.7.11.1]
113913342  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
113913864  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
113913870  ATM; serine-protein kinase ATM isoform X1 [KO:K04728] [EC:2.7.11.1]
113913985  SESN3; sestrin-3 isoform X1 [KO:K10141]
113914083  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
113914388  PIDD1; p53-induced death domain-containing protein 1 [KO:K10130]
113914894  [KO:K10808] [EC:1.17.4.1]
113915077  CD82; CD82 antigen [KO:K06509]
113915086  EI24; etoposide-induced protein 2.4 homolog isoform X1 [KO:K10134]
113915274  [KO:K04722]
113915303  CHEK1; serine/threonine-protein kinase Chk1 isoform X1 [KO:K02216] [EC:2.7.11.1]
113915608  SESN2; sestrin-2 [KO:K20394]
113916383  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
113916711  SHISA5; protein shisa-5 isoform X1 [KO:K10135]
113916959  ATR; serine/threonine-protein kinase ATR isoform X1 [KO:K06640] [EC:2.7.11.1]
113917397  ZMAT3; zinc finger matrin-type protein 3 isoform X1 [KO:K10137]
113918785  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
113919794  STEAP3; metalloreductase STEAP3 isoform X1 [KO:K10142] [EC:1.16.1.-]
113919983  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
113920143  RPRM; protein reprimo [KO:K10128]
113921316  GTSE1; G2 and S phase-expressed protein 1 isoform X1 [KO:K10129]
113921399  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
113921409  APAF1; apoptotic protease-activating factor 1 [KO:K02084]
113921783  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
113921804  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
113921844  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
113921871  ZNF385A; zinc finger protein 385A isoform X1 [KO:K26543]
113922232  IGF1; insulin-like growth factor I isoform X1 [KO:K05459]
113922975  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
113923806  AIFM2; LOW QUALITY PROTEIN: ferroptosis suppressor protein 1 [KO:K22745]
113923881  CDK1; cyclin-dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]
113924077  RRM2B; ribonucleoside-diphosphate reductase subunit M2 B isoform X1 [KO:K10808] [EC:1.17.4.1]
113924509  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
113924554  RCHY1; RING finger and CHY zinc finger domain-containing protein 1 isoform X1 [KO:K10144] [EC:2.3.2.27]
113925592  [KO:K10134]
113925670  CCNG2; cyclin-G2 isoform X1 [KO:K10146]
113926716  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
113926733  SESN1; sestrin-1 isoform X1 [KO:K10141]
113926916  [KO:K10136]
113926974  [KO:K08738]
113927327  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
113929111  CCNB1; G2/mitotic-specific cyclin-B1 isoform X1 [KO:K05868]
113929430  CCNG1; cyclin-G1 [KO:K10145]
113930564  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
113931318  [KO:K04506] [EC:2.3.2.27]
113931797  [KO:K02087] [EC:2.7.11.22 2.7.11.23]
113932191  MDM4; protein Mdm4 isoform X1 [KO:K10127]
113932273  COP1; E3 ubiquitin-protein ligase COP1 isoform X1 [KO:K10143] [EC:2.3.2.27]
113933082  SERPINE1; plasminogen activator inhibitor 1 [KO:K03982]
113933375  GORAB; RAB6-interacting golgin isoform X2 [KO:K19748]
113933431  TSC2; tuberin isoform X1 [KO:K07207]
113934058  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
113935677  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
113935952  SIAH1; E3 ubiquitin-protein ligase SIAH1 isoform X1 [KO:K04506] [EC:2.3.2.27]
113936070  BBC3; bcl-2-binding component 3 [KO:K10132]
113936089  SFN; 14-3-3 protein sigma [KO:K06644]
113936689  PPP1R13L; LOW QUALITY PROTEIN: relA-associated inhibitor [KO:K27356]
113936714  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
113936987  BCL2L1; bcl-2-like protein 1 [KO:K04570]
113937404  TP53I3; quinone oxidoreductase PIG3 isoform X1 [KO:K10133] [EC:1.-.-.-]
113937988  RRM2; ribonucleoside-diphosphate reductase subunit M2 [KO:K10808] [EC:1.17.4.1]
113938410  [KO:K10808] [EC:1.17.4.1]
113939587  TP53; cellular tumor antigen p53 isoform X1 [KO:K04451]
118356724  [KO:K05868]
Reference
  Authors
Levine AJ, Hu W, Feng Z.
  Title
The P53 pathway: what questions remain to be explored?
  Journal
Cell Death Differ 13:1027-36 (2006)
DOI:10.1038/sj.cdd.4401910
Reference
  Authors
Harris SL, Levine AJ.
  Title
The p53 pathway: positive and negative feedback loops.
  Journal
Oncogene 24:2899-908 (2005)
DOI:10.1038/sj.onc.1208615
Reference
  Authors
Balint E E, Vousden KH.
  Title
Activation and activities of the p53 tumour suppressor protein.
  Journal
Br J Cancer 85:1813-23 (2001)
DOI:10.1054/bjoc.2001.2128
Reference
  Authors
Taylor WR, Stark GR.
  Title
Regulation of the G2/M transition by p53.
  Journal
Oncogene 20:1803-15 (2001)
DOI:10.1038/sj.onc.1204252
Reference
  Authors
Hofseth LJ, Hussain SP, Harris CC.
  Title
p53: 25 years after its discovery.
  Journal
Trends Pharmacol Sci 25:177-81 (2004)
DOI:10.1016/j.tips.2004.02.009
Reference
  Authors
Pietenpol JA, Stewart ZA.
  Title
Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.
  Journal
Toxicology 181-182:475-81 (2002)
DOI:10.1016/S0300-483X(02)00460-2
Reference
  Authors
Tokino T, Nakamura Y.
  Title
The role of p53-target genes in human cancer.
  Journal
Crit Rev Oncol Hematol 33:1-6 (2000)
DOI:10.1016/S1040-8428(99)00051-7
Reference
  Authors
Hermeking H, Benzinger A.
  Title
14-3-3 proteins in cell cycle regulation.
  Journal
Semin Cancer Biol 16:183-92 (2006)
DOI:10.1016/j.semcancer.2006.03.002
Reference
  Authors
Sherr CJ.
  Title
Divorcing ARF and p53: an unsettled case.
  Journal
Nat Rev Cancer 6:663-73 (2006)
DOI:10.1038/nrc1954
Reference
  Authors
Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ.
  Title
The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
  Journal
Cancer Res 67:3043-53 (2007)
DOI:10.1158/0008-5472.CAN-06-4149
Reference
  Authors
Resnick-Silverman L, Manfredi JJ
  Title
Two Faces of SIVA.
  Journal
Cancer Discov 5:581-3 (2015)
DOI:10.1158/2159-8290.CD-15-0484
Reference
  Authors
Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R
  Title
Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.
  Journal
J Cell Sci 122:2651-61 (2009)
DOI:10.1242/jcs.049940
Reference
  Authors
Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV
  Title
The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis.
  Journal
J Carcinog 8:2 (2009)
DOI:10.4103/1477-3163.45389
Reference
  Authors
Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N
  Title
A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).
  Journal
FEBS Lett 524:163-71 (2002)
DOI:10.1016/S0014-5793(02)03049-1
Reference
  Authors
Hu Y, Ge W, Wang X, Sutendra G, Zhao K, Dedeic Z, Slee EA, Baer C, Lu X
  Title
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-kappaB.
  Journal
Oncotarget 6:42478-90 (2015)
DOI:10.18632/oncotarget.6478
Related
pathway
zca04110  Cell cycle
zca04210  Apoptosis
zca04218  Cellular senescence
KO pathway
ko04115   

DBGET integrated database retrieval system